FCM
ADAP

Frontier Capital Management’s Adaptimmune Therapeutics ADAP Stock Holding History

Frontier Capital Management’s Portfolio ADAP Stock Details ADAP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-698,694
Closed -$9.47M – 288
2018
Q3 		$9.47M Buy
698,694
+543,809
+351% +$7.37M 0.06% 242
2018
Q2 		$1.84M Buy
+154,885
New +$1.84M 0.01% 290